Milyon USD cinsinden finanslar. Mali yıl Şubat - Ocak'tır.
Breakdown
TTM
06/30/2025
06/30/2024
06/30/2023
06/30/2022
06/30/2021
Hasılat
13
13
12
9
8
7
Hasılat Artışı (YoY)
18%
8%
33%
13%
14%
0%
Satınalma Maliyeti
6
6
5
4
4
5
Brüt Kâr
6
6
6
5
3
2
Satış, Genel ve İdari
6
6
5
4
6
8
Araştırma ve Geliştirme
--
--
--
--
0
0
İşletme Giderleri
7
7
7
6
8
11
Diğer Finansman Gelirleri (Giderleri)
--
--
--
--
--
--
Kâr Öncesi Gelir
0
-1
0
0
-7
-22
Kira Vergisi Gideri
--
--
--
--
--
--
Net Kâr
0
-1
0
0
-7
-28
Net Income Growth
Kâr Artışı
--
--
--
-100%
-75%
-65%
Dolaşım Daki Hisse Senetleri (Dilüte Edilmiş)
31.26
31.26
28.56
25.26
25.26
22.59
Hisse Değişimi (Yıllık Üst Üste)
4%
9%
13%
0%
12%
5%
EPS (Diluted)
-0.02
-0.03
0.03
0
-0.27
-1.26
EPS Artışı
-212%
-224%
-521%
-97%
-79%
-66%
Öz sermaye akışı
0
0
0
-1
-4
-9
Hisse Başı Öz Kaynak Akışı
--
--
--
--
--
--
Brüt Karşılık
46.15%
46.15%
50%
55.55%
37.5%
28.57%
Faaliyet Kâr Marjı
0%
0%
0%
0%
-62.5%
-114.28%
Kâr Marjı
0%
-7.69%
0%
0%
-87.5%
-400%
Özsermaye Karlılık Oranı
0%
0%
0%
-11.11%
-50%
-128.57%
EBITDA
0
1
1
1
-3
-6
EBITDA Marjinali
0%
7.69%
8.33%
11.11%
-37.5%
-85.71%
D&A EBITDA için
0
1
1
1
2
2
Faaliyet Kârı
0
0
0
0
-5
-8
Faaliyet Kâr Marjı
0%
0%
0%
0%
-62.5%
-114.28%
Verilen Vergi Oranı
--
--
--
--
--
--
Önemli İstatistikler
Önceki Kapanış
$0.1407
Açılış fiyatı
$0.1402
Günün Aralığı
$0.138 - $0.1402
52 haftalık aralık
$0.0057 - $0.2612
İşlem hacmi
382
Ort.Hacim
4.7K
EPS (TTM)
-0.02
Dividend yield
--
Piyasa Değeri
$4.3M
DHBUF nedir?
Delivra Health Brands, Inc. is a cannabis company, which engages in the development and provision of health and wellness packaged goods to consumers and patients in regulated markets. The company is headquartered in Vancouver, British Columbia. The company went IPO on 2010-02-02. The firm provides products that help with pain, sleep, anxiety, and performance through its brands LivRelief and Dream Water. The company operates a portfolio of brands under its Consumer Division consisting of Dream Products Inc. and Delivra Corp. Dream Water provides non-habit-forming sleep solutions in formats to suit various consumer needs. The company features its proprietary SleepStat blend, a combination of melatonin, gamma-aminobutyric acid, and 5-hydroxytryptophan. Its product range includes 74ml (2.5oz) liquid sleep shots, gummies, and powder. Delivra Corp. manufactures and sells a growing line of topical creams with the proprietary transdermal delivery system platform under the LivRelief brand for conditions, such as joint and muscle pain, nerve pain, varicose veins, and wound healing creams. LivRelief Infused launched cannabidol and tetrahydrocannabinol-infused topical formulations through licensing agreements.